19-42248868-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006494.4(ERF):​c.1244C>T​(p.Ala415Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 1,607,218 control chromosomes in the GnomAD database, including 276 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A415A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.012 ( 13 hom., cov: 32)
Exomes 𝑓: 0.018 ( 263 hom. )

Consequence

ERF
NM_006494.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0350

Publications

4 publications found
Variant links:
Genes affected
ERF (HGNC:3444): (ETS2 repressor factor) ETS2 is a transcription factor and protooncogene involved in development, apoptosis, and the regulation of telomerase. The protein encoded by this gene binds to the ETS2 promoter and is a strong repressor of ETS2 transcription. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
ERF Gene-Disease associations (from GenCC):
  • Chitayat syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • craniosynostosis 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, ClinGen, Genomics England PanelApp
  • Crouzon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated scaphocephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002723068).
BP6
Variant 19-42248868-G-A is Benign according to our data. Variant chr19-42248868-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 476625.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0117 (1781/152190) while in subpopulation NFE AF = 0.0182 (1240/67964). AF 95% confidence interval is 0.0174. There are 13 homozygotes in GnomAd4. There are 868 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1781 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERFNM_006494.4 linkc.1244C>T p.Ala415Val missense_variant Exon 4 of 4 ENST00000222329.9 NP_006485.2 P50548-1A0A024R0L4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERFENST00000222329.9 linkc.1244C>T p.Ala415Val missense_variant Exon 4 of 4 1 NM_006494.4 ENSP00000222329.3 P50548-1
ENSG00000268643ENST00000594664.1 linkc.22+6110C>T intron_variant Intron 1 of 4 3 ENSP00000470087.1 M0QYV0

Frequencies

GnomAD3 genomes
AF:
0.0117
AC:
1781
AN:
152074
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00312
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00635
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00791
Gnomad SAS
AF:
0.00705
Gnomad FIN
AF:
0.0193
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.0140
AC:
3275
AN:
233218
AF XY:
0.0142
show subpopulations
Gnomad AFR exome
AF:
0.00363
Gnomad AMR exome
AF:
0.00562
Gnomad ASJ exome
AF:
0.00614
Gnomad EAS exome
AF:
0.00568
Gnomad FIN exome
AF:
0.0211
Gnomad NFE exome
AF:
0.0206
Gnomad OTH exome
AF:
0.0126
GnomAD4 exome
AF:
0.0180
AC:
26133
AN:
1455028
Hom.:
263
Cov.:
33
AF XY:
0.0177
AC XY:
12820
AN XY:
723626
show subpopulations
African (AFR)
AF:
0.00287
AC:
96
AN:
33416
American (AMR)
AF:
0.00586
AC:
261
AN:
44564
Ashkenazi Jewish (ASJ)
AF:
0.00658
AC:
171
AN:
25996
East Asian (EAS)
AF:
0.0136
AC:
537
AN:
39612
South Asian (SAS)
AF:
0.00982
AC:
845
AN:
86010
European-Finnish (FIN)
AF:
0.0191
AC:
938
AN:
49132
Middle Eastern (MID)
AF:
0.00279
AC:
16
AN:
5732
European-Non Finnish (NFE)
AF:
0.0201
AC:
22331
AN:
1110368
Other (OTH)
AF:
0.0156
AC:
938
AN:
60198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1588
3176
4763
6351
7939
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0117
AC:
1781
AN:
152190
Hom.:
13
Cov.:
32
AF XY:
0.0117
AC XY:
868
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00311
AC:
129
AN:
41528
American (AMR)
AF:
0.00634
AC:
97
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3470
East Asian (EAS)
AF:
0.00792
AC:
41
AN:
5174
South Asian (SAS)
AF:
0.00705
AC:
34
AN:
4820
European-Finnish (FIN)
AF:
0.0193
AC:
205
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0182
AC:
1240
AN:
67964
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
82
163
245
326
408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
1
Bravo
AF:
0.0106
TwinsUK
AF:
0.0183
AC:
68
ALSPAC
AF:
0.0153
AC:
59
ESP6500AA
AF:
0.00303
AC:
13
ESP6500EA
AF:
0.0169
AC:
141
ExAC
AF:
0.0152
AC:
1834
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.0159
EpiControl
AF:
0.0138

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 07, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

TWIST1-related craniosynostosis Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.7
DANN
Benign
0.96
DEOGEN2
Benign
0.098
T;.
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.62
T;T
MetaRNN
Benign
0.0027
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N;.
PhyloP100
-0.035
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
0.11
N;N
REVEL
Benign
0.071
Sift
Benign
0.36
T;T
Sift4G
Benign
0.78
T;T
Polyphen
0.0010
B;.
Vest4
0.020
MPC
0.63
ClinPred
0.0038
T
GERP RS
2.9
Varity_R
0.031
gMVP
0.11
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139842507; hg19: chr19-42753020; COSMIC: COSV55897221; COSMIC: COSV55897221; API